Major vault protein forms complexes with hypoxia-inducible factor (HIF)-1α and reduces HIF-1α level in ACHN human renal adenocarcinoma cells

Cancer Science

Volumn 101, Issue 4, 2010, Pages 920-926

  Iwashita, Ken ichi ^a   Ikeda, Ryuji ^a   Takeda, Yasuo ^a   Sumizawa, Tomoyuki ^b   Furukawa, Tatsuhiko ^a   Yamaguchi, Tatsuya ^a   Akiyama, Shin ichi ^a   Yamada, Katsushi ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1ALPHA; LUNG RESISTANCE PROTEIN; MESSENGER RNA; VASCULOTROPIN; RIBONUCLEOPROTEIN;

ARTICLE; CARCINOMA CELL; GENE EXPRESSION; HUMAN; HUMAN CELL; HYPOXIA; KIDNEY CARCINOMA; PRIORITY JOURNAL; PROTEIN DEGRADATION; RNA INTERFERENCE; UBIQUITINATION; ADENOCARCINOMA; CELL HYPOXIA; GENETICS; KIDNEY TUMOR; METABOLISM; TUMOR CELL LINE;

ADENOCARCINOMA; CELL HYPOXIA; CELL LINE, TUMOR; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; KIDNEY NEOPLASMS; RNA INTERFERENCE; RNA, MESSENGER; UBIQUITINATION; VAULT RIBONUCLEOPROTEIN PARTICLES;

EID: 77957282325     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2009.01481.x     Document Type: Article

References (38)

1. Kedersha NL, Rome LH. Isolation and characterization of a novel ribonucleoprotein particle: large structures contain a single species of small RNA. J Cell Biol 1986; 103: 699-709.
2. Vasu SK, Kedersha NL, Rome LH. cDNA cloning and disruption of the major vault protein α gene (mvpA) in Dictyostelium discoideum. J Biol Chem 1993; 268: 15356-60.
3. Kickhoefer VA, Rome LH. The sequence of a cDNA encoding the major vault protein from Rattus norvegicus. Gene 1994; 151: 257-60.
4. Kickhoefer VA, Siva AC, Kedersha NL et al. The 193-kD vault protein, VPARP, is a novel poly(ADP-ribose) polymerase. J Cell Biol 1999; 146: 917-28.
5. Kickhoefer VA, Stephen AG, Harrington L, Robinson MO, Rome LH. Vaults and telomerase share a common subunit, TEP1. J Biol Chem 1999; 274: 32712-7.
6. Harrington L, McPhail T, Mar V et al. A mammalian telomerase-associated protein. Science 1997; 275: 973-7.
7. Kickhoefer VA, Searles RP, Kedersha NL, Garber ME, Johnson DL, Rome LH. Vault ribonucleoprotein particles from rat and bullfrog contain a related small RNA that is transcribed by RNA polymerase III. J Biol Chem 1993; 268: 7868-73.
8. Kong LB, Siva AC, Kickhoefer VA, Rome LH, Stewart PL. RNA location and modeling of a WD40 repeat domain within the vault. RNA 2000; 6: 890-900.
9. Kedersha NL, Miquel MC, Bittner D, Rome LH. Vaults. II. Ribonucleoprotein structures are highly conserved among higher and lower eukaryotes. J Cell Biol 1990; 110: 895-901.
10. Scheffer GL, Wijngaard PL, Flens MJ et al. The drug resistance-related protein LRP is the human major vault protein. Nat Med 1995; 1: 578-82.
11. r 110, 000 vesicular protein in non-P-glycoprotein-mediated multidrug resistance. Cancer Res 1993; 53: 1475-9.
12. Izquierdo MA, Shoemaker RH, Flens MJ et al. Overlapping phenotypes of multidrug resistance among panels of human cancer-cell lines. Int J Cancer 1996; 65: 230-7.
13. Izquierdo MA, Scheffer GL, Flens MJ, Shoemaker RH, Rome LH, Scheper RJ. Relationship of LRP-human major vault protein to in vitro and clinical resistance to anticancer drugs. Cytotechnology 1996; 19: 191-7.
14. Kickhoefer VA, Rajavel KS, Scheffer GL, Dalton WS, Scheper RJ, Rome LH. Vaults are up-regulated in multidrug-resistant cancer cell lines. J Biol Chem 1998; 273: 8971-4.
15. Siva AC, Raval-Fernandes S, Stephen AG et al. Up-regulation of vaults may be necessary but not sufficient for multidrug resistance. Int J Cancer 2001; 92: 195-202.
16. Huffman KE, Corey DR. Major vault protein does not play a role in chemoresistance or drug localization in a non-small cell lung cancer cell line. Biochemistry 2005; 44: 2253-61.
17. Mossink MH, van Zon A, Franzel-Luiten E et al. Disruption of the murine major vault protein (MVP/LRP) gene does not induce hypersensitivity to cytostatics. Cancer Res 2002; 62: 7298-304.
18. Shimamoto Y, Sumizawa T, Haraguchi M et al. Direct activation of the human major vault protein gene by DNA-damaging agents. Oncol Rep 2006; 15: 645-52.
19. Ikeda R, Iwashita KI, Sumizawa T et al. Hyperosmotic stress up-regulates the expression of major vault protein in SW620 human colon cancer cells. Exp Cell Res 2008; 314: 3017-26.
20. Stein U, Jurchott K, Schlafke M, Hohenberger P. Expression of multidrug resistance genes MVP, MDR1, and MRP1 determined sequentially before, during, and after hyperthermic isolated limb perfusion of soft tissue sarcoma and melanoma patients. J Clin Oncol 2002; 20: 3282-92.
21. Zhu H, Chen XP, Luo SF et al. Hypoxia-inducible factor-1α dependent expression and significance of the related multidrug resistance genes induced by hypoxia in human hepatocarcinoma cell. Zhonghua Wai Ke Za Zhi 2005; 43: 277-81.
22. Vaupel P, Kallinowski F, Okunieff P. Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. Cancer Res 1989; 49: 6449-65.
23. Semenza GL, Wang GL. A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation. Mol Cell Biol 1992; 12: 5447-54.
24. Wiesener MS, Jurgensen JS, Rosenberger C et al. Widespread hypoxia-inducible expression of HIF-2α in distinct cell populations of different organs. FASEB J 2003; 17: 271-3.
25. 2-regulated prolyl hydroxylation. Science 2001; 292: 468-72.
26. Ohh M, Park CW, Ivan M et al. Ubiquitination of hypoxia-inducible factor requires direct binding to the β-domain of the von Hippel-Lindau protein. Nat Cell Biol 2000; 2: 423-7.
27. Kitazono M, Sumizawa T, Takebayashi Y et al. Multidrug resistance and the lung resistance-related protein in human colon carcinoma SW-620 cells. J Natl Cancer Inst 1999; 91: 1647-53.
28. Zheng CL, Sumizawa T, Che XF et al. Characterization of MVP and VPARP assembly into vault ribonucleoprotein complexes. Biochem Biophys Res Commun 2005; 326: 100-7.
29. Brummelkamp TR, Bernards R, Agami R. A system for stable expression of short interfering RNAs in mammalian cells. Science 2002; 296: 550-3.
30. Mrazek J, Kreutmayer SB, Grasser FA, Polacek N, Huttenhofer A. Subtractive hybridization identifies novel differentially expressed ncRNA species in EBV-infected human B cells. Nucleic Acids Res 2007; 35: e73.
31. Motsch N, Pfuhl T, Mrazek J, Barth S, Grasser FA. Epstein-Barr virus-encoded latent membrane protein 1 (LMP1) induces the expression of the cellular microRNA miR-146a. RNA Biol 2007; 4: 131-7.
32. Kolli S, Zito CI, Mossink MH, Wiemer EA, Bennett AM. The major vault protein is a novel substrate for the tyrosine phosphatase SHP-2 and scaffold protein in epidermal growth factor signaling. J Biol Chem 2004; 279: 29374-85.
33. Kowalski MP, Dubouix-Bourandy A, Bajmoczi M et al. Host resistance to lung infection mediated by major vault protein in epithelial cells. Science 2007; 317: 130-2.
34. β homologous domain. Cell 1992; 71: 791-801.
35. Yi C, Li S, Chen X et al. Major vault protein, in concert with constitutively photomorphogenic 1, negatively regulates c-Jun-mediated activator protein 1 transcription in mammalian cells. Cancer Res 2005; 65: 5835-40.
36. Baek JH, Mahon PC, Oh J et al. OS-9 interacts with hypoxia-inducible factor 1α and prolyl hydroxylases to promote oxygen-dependent degradation of HIF-1α. Mol Cell 2005; 17: 503-12.
37. Baek JH, Liu YV, McDonald KR et al. Spermidine/spermine-N1-acetyltransferase 2 is an essential component of the ubiquitin ligase complex that regulates hypoxia-inducible factor 1α. J Biol Chem 2007; 282: 23572-80.
38. Wong W, Goehring AS, Kapiloff MS, Langeberg LK, Scott JD. mAKAP compartmentalizes oxygen-dependent control of HIF-1α. Sci Signal 2008; 1: ra18.